166 related articles for article (PubMed ID: 25490990)
1. A prospective follow-up study of the relationship between C-reactive protein and human cancer risk in the Chinese Kailuan Female Cohort.
Wang G; Li N; Chang S; Bassig BA; Guo L; Ren J; Su K; Li F; Chen S; Wu S; Zou Y; Dai M; Zheng T; He J
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):459-65. PubMed ID: 25490990
[TBL] [Abstract][Full Text] [Related]
2. [A prospective follow-up study on the association between serum level of C-reactive protein and risk of digestive system cancers in Chinese women].
Wang G; Cao LY; Chen SH; Xie SH; Feng XS; Lyu ZY; Guo LW; Li F; Su K; Chang S; Ren JS; Dai M; Li N; Wu SL; He J
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):876-880. PubMed ID: 27998450
[No Abstract] [Full Text] [Related]
3. Association Between Baseline C-Reactive Protein and the Risk of Lung Cancer: A Prospective Population-Based Cohort Study.
Yin J; Wang G; Wu Z; Lyu Z; Su K; Li F; Feng X; Guo LW; Chen Y; Xie S; Cui H; Li J; Ren J; Shi JF; Chen S; Wu S; Dai M; Li N; He J
Cancer Prev Res (Phila); 2022 Nov; 15(11):747-754. PubMed ID: 35896151
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between inflammatory markers and the risk of colorectal cancer in Kailuan male cohort].
Wang G; Xu WG; Li F; Su K; Li N; Lü ZY; Feng XS; Wei LP; Chen HD; Chen YH; Guo LW; Cui H; Yang WJ; Li ZF; Ren JS; Wu SL; Shi JF; Dai M; He J
Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(40):3158-3161. PubMed ID: 29081162
[No Abstract] [Full Text] [Related]
5. [Association between the level of high sensitivity C-reactive protein and risk of breast cancer among non-diabetic females: a prospective study in Kailuan group].
Wang G; Li N; Cao L; Chen S; Guo L; Su K; Li F; Cui H; He J; Dai M; Zou Y; Sun D; Wu S
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):944-8. PubMed ID: 25623772
[TBL] [Abstract][Full Text] [Related]
6. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
[No Abstract] [Full Text] [Related]
7. C-reactive protein concentration and risk of selected obesity-related cancers in the Women's Health Initiative.
Brasky TM; Kabat GC; Ho GYF; Thomson CA; Nicholson WK; Barrington WE; Bittoni MA; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2018 Sep; 29(9):855-862. PubMed ID: 30046933
[TBL] [Abstract][Full Text] [Related]
8. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.
Prizment AE; Folsom AR; Dreyfus J; Anderson KE; Visvanathan K; Joshu CE; Platz EA; Pankow JS
Cancer Causes Control; 2013 Dec; 24(12):2077-87. PubMed ID: 24036889
[TBL] [Abstract][Full Text] [Related]
9. High-Sensitivity C-Reactive Protein and Risks of All-Cause and Cause-Specific Mortality in a Japanese Population.
Nisa H; Hirata A; Kohno M; Kiyohara C; Ohnaka K
Asian Pac J Cancer Prev; 2016; 17(5):2643-8. PubMed ID: 27268644
[TBL] [Abstract][Full Text] [Related]
10. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
Allin KH; Nordestgaard BG; Flyger H; Bojesen SE
Breast Cancer Res; 2011 Jun; 13(3):R55. PubMed ID: 21639875
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.
Zuo H; Tell GS; Vollset SE; Ueland PM; Nygård O; Midttun Ø; Meyer K; Ulvik A; Eussen SJ
Cancer; 2014 Nov; 120(21):3370-7. PubMed ID: 24948355
[TBL] [Abstract][Full Text] [Related]
12. Associations Between High-Sensitivity C-Reactive Protein and All-Cause Mortality Among Oldest-Old in Chinese Longevity Areas: A Community-Based Cohort Study.
Chen PL; Li ZH; Yang HL; Cao ZJ; Cheng X; Zhao F; Zhang XR; Lv YB; Li FR; Zhou YF; Li HN; Qu YL; Yin ZX; Liu L; Wu XB; Shi XM; Mao C
Front Public Health; 2022; 10():824783. PubMed ID: 35211447
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population.
Allin KH; Bojesen SE; Nordestgaard BG
Int J Cancer; 2016 Oct; 139(7):1493-500. PubMed ID: 27194008
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between inflammatory markers and the risk of lung cancer: a prospective cohort study].
Wang G; Wei LP; Li N; Xu WG; Su K; Li F; Tan FW; Lyu ZY; Feng XS; Li X; Chen HD; Chen YH; Guo LW; Cui H; Jiao PF; Liu HX; Ren JS; Wu SL; Shi JF; Dai M; He J
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):633-637. PubMed ID: 31434457
[No Abstract] [Full Text] [Related]
15. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
[TBL] [Abstract][Full Text] [Related]
16. Prehypertension subtype with elevated C-reactive protein: risk of ischemic stroke in a general Japanese population.
Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Onodera M; Koeda Y; Kawarura K; Terayama Y; Yoshida Y; Ogawa A; Okayama A; Nakamura M;
Am J Hypertens; 2010 Oct; 23(10):1108-13. PubMed ID: 20596037
[TBL] [Abstract][Full Text] [Related]
17. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.
Su J; Cui L; Yang W; Shi H; Jin C; Shu R; Li H; Zeng X; Wu S; Gao X
PLoS One; 2019; 14(2):e0211946. PubMed ID: 30768617
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis.
Zhu M; Ma Z; Zhang X; Hang D; Yin R; Feng J; Xu L; Shen H
BMC Med; 2022 Sep; 20(1):301. PubMed ID: 36117174
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.
van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH
Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002
[TBL] [Abstract][Full Text] [Related]
20. Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study.
Wu J; Cai Q; Li H; Cai H; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
Carcinogenesis; 2013 Dec; 34(12):2799-803. PubMed ID: 23985781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
